Background: Peripheral lymphadenopathy is the most common disease in extrapulmonary TB diseases, TB bacteria follow the lymph node route to the lymph nodes, causing lymphadenitis, swollen lymphadenopathy, persistent lymphadenopathy. Diagnosing peripheral lymphadenopathy is difficult, especially requiring evidence of TB bacteria. The surgical treatment resolves the complication of lymph node abscess, avoids scars, bad shrinkage, heavy aesthetic effects.
Objectives: Evaluate the role and results of surgery in the treatment of peripheral lymph node tuberculosis.
Subjects and methods: A cross-sectional descriptive study of 105 patients with tuberculosis of the peripheral lymph nodes from June 1, 2020, to June 30, 2021, who underwent surgical curettage to clear inflammation and remove pus., take tissue necrosis and test LPA, MGIT (bactec), histopathology. All patients were treated with TB drugs according to the National TB Program's regimen of 12 months (2RHZE/10RHE), wound healing time after surgery and detection of drug resistance.
Results: 105 patients, 67 women, 38 men, mean age 32.26 ± 12.1; cervical lymph node location 97/105 (92.4%), right neck more than left neck (58 and 36), 77 patients with purulent necrotizing lymphadenitis, 28 patients with biopsy results of tuberculosis, tuberculosis inflamed tissue 97 (92.4%), LPA 25/105 (23/8%), MGIT 59/105 (56.2%) was positive. Multidrug resistance has four patients with rifampicin (4/59); The most resistant drugs are Streptomycin and Isoniazid. Conclusion: Surgical treatment of peripheral lymph node TB achieves 2 goals: resolving complications of lymph node TB and taking specimens for testing to detect drug resistance